GRAL
Ticker
Grail Inc
Company
Diagnostics
Industry
Healthcare
Sector
2021
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
 280.2%67.6%34.9% 20.5%
Revenue Growth QoQ
Gross Margin
-284.4%-209.6%-102.7%-62.1% -47.5%
EBITDA Margin
-8259.6%-9519.6%-1457.2%-1617.2% -294.6%
Operating Margin
-8659.6%-9798.2%-1627.6%-1743.0% -405.2%
Profit Margin
-8539.4%-9719.3%-1574.2%-1613.9% -286.4%
FCF / EBITDA
62.8%11.0%44.9%28.7% 78.9%